San Diego-based Invivoscribe Technologies Inc., a privately held life science company, announced it has launched Genection Inc.
Genection provides physicians with a dedicated online platform for global access to the entire clinically-actionable genetic test menu, including both routine and esoteric genetic tests, exome and whole genome sequencing, cancer somatic mutation testing, and pharmacogenomics.
Prescribing physicians have access to genetic tests that may currently be unavailable, overlooked or even inaccessible through their patients' managed care plans and health care institutions.
Genection has agreements in place with several CLIA and CAP accredited laboratories, as well as sequencing centers.
"Our initial partners include ARUP Laboratories, Foundation Medicine, Cypher Genomics, the Laboratory for Personalized Molecular Medicine (LabPMM) in the U.S., as well as its ISO15189 compliant laboratory (LabPMM GmbH) in Martinsried, Germany," said Suzanne Graham, Genection's senior manager of business development. "Genection also has established relationships with sequencing providers, including Illumina and Ambry Genetics."
Genection has alliances with a consortium of genetic counselors, to provide current informed decision making support, reducing costs of the informed consent process, and helping to avoid unnecessary testing.